WEBSITE BSE:543238 NSE: UTIAMC Inc. Year: 2002 Industry: Finance - Asset Management
Last updated: 15:55
UTI Asset Management Company (P) Ltd. is a privately owned funding supervisor. It manages mutual funds for its clients. The organization invests in money marketplace, fixed income, and public equity markets of India. It employs in-residence studies while making its investments. UTI Asset Management Company (P) Ltd. become incorporated on November 14, 2002 and is primarily based in Mumbai, India.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹13658 Cr.
Stock P/E 16.8
P/B 3
Current Price ₹1062.7
Book Value ₹ 352
Face Value 10
52W High ₹1495
Dividend Yield 4.52%
52W Low ₹ 906.4
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Revenue | 404 | 449 | 416 | 529 | 538 | 418 | 376 | 547 | 419 | 517 |
| Other Income | 2 | 1 | 4 | 5 | 2 | 3 | 0 | 2 | 3 | 1 |
| Total Income | 406 | 450 | 420 | 534 | 540 | 420 | 376 | 549 | 421 | 518 |
| Total Expenditure | 173 | 176 | 188 | 178 | 190 | 185 | 207 | 207 | 241 | 215 |
| Operating Profit | 233 | 274 | 233 | 356 | 350 | 236 | 169 | 342 | 180 | 303 |
| Interest Expense | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Depreciation | 10 | 10 | 12 | 11 | 11 | 11 | 12 | 12 | 13 | 13 |
| Profit Before Tax | 220 | 261 | 218 | 341 | 336 | 221 | 154 | 326 | 164 | 178 |
| Provision for Tax | 37 | 57 | 37 | 67 | 73 | 48 | 52 | 72 | 32 | 40 |
| Profit After Tax | 183 | 203 | 181 | 274 | 263 | 174 | 102 | 254 | 132 | 138 |
| Adjustments | 0 | -18 | -19 | -20 | -24 | -23 | -15 | -17 | -19 | -17 |
| Profit After Adjustments | 183 | 186 | 163 | 254 | 239 | 151 | 87 | 237 | 113 | 121 |
| Adjusted Earnings Per Share | 14.4 | 14.6 | 12.8 | 20 | 18.8 | 11.8 | 6.8 | 18.5 | 8.8 | 9.4 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Revenue | 1035 | 1172 | 1053 | 865 | 1169 | 1319 | 1267 | 1737 | 1851 | 1859 |
| Other Income | 14 | 11 | 30 | 36 | 4 | 8 | 23 | 7 | 9 | 6 |
| Total Income | 1049 | 1183 | 1084 | 901 | 1173 | 1327 | 1290 | 1744 | 1860 | 1864 |
| Total Expenditure | 493 | 629 | 568 | 514 | 526 | 621 | 655 | 704 | 750 | 870 |
| Operating Profit | 555 | 554 | 515 | 387 | 647 | 706 | 635 | 1040 | 1110 | 994 |
| Interest Expense | 9 | 0 | 2 | 12 | 8 | 9 | 10 | 11 | 13 | 12 |
| Depreciation | 26 | 14 | 16 | 34 | 36 | 37 | 40 | 42 | 46 | 50 |
| Profit Before Tax | 521 | 539 | 497 | 341 | 603 | 660 | 586 | 987 | 1052 | 822 |
| Provision for Tax | 125 | 142 | 145 | 66 | 109 | 126 | 146 | 185 | 239 | 196 |
| Profit After Tax | 395 | 397 | 352 | 275 | 494 | 535 | 440 | 802 | 813 | 626 |
| Adjustments | 5 | -40 | 5 | -3 | -0 | -0 | -2 | -36 | -81 | -68 |
| Profit After Adjustments | 400 | 357 | 357 | 271 | 494 | 534 | 437 | 766 | 731 | 558 |
| Adjusted Earnings Per Share | 31.6 | 28.2 | 28.1 | 21.4 | 39 | 42.1 | 34.4 | 60.2 | 57.2 | 43.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 7% | 12% | 16% | 0% |
| Operating Profit CAGR | 7% | 16% | 23% | 0% |
| PAT CAGR | 1% | 15% | 24% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 1% | 15% | 14% | NA% |
| ROE Average | 18% | 17% | 16% | 16% |
| ROCE Average | 24% | 21% | 21% | 21% |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 2026 | 2375 | 2616 | 2772 | 3252 | 3620 | 3868 | 4388 | 4599 |
| Minority's Interest | 105 | 42 | 37 | 11 | 11 | 11 | 0 | 585 | 561 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liability | 308 | 325 | 171 | 171 | 340 | 433 | 348 | 171 | 258 |
| Other Liabilities & Provisions | 64 | 49 | 107 | 211 | 209 | 197 | 135 | 386 | 509 |
| Total Liabilities | 2503 | 2791 | 2930 | 3165 | 3812 | 4261 | 4352 | 5530 | 5928 |
| Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 7 |
| Investments | 1812 | 2149 | 1535 | 1689 | 1693 | 1193 | 1301 | 2255 | 2273 |
| Fixed Assets | 369 | 261 | 257 | 362 | 349 | 348 | 359 | 285 | 286 |
| Other Loans | 9 | 21 | 33 | 28 | 32 | 18 | 15 | 223 | 294 |
| Other Non Current Assets | 10 | 5 | 131 | 157 | 68 | 84 | 13 | 178 | 269 |
| Current Assets | 303 | 343 | 964 | 918 | 1659 | 2608 | 2654 | 2453 | 2676 |
| Total Assets | 2503 | 2791 | 2930 | 3165 | 3812 | 4261 | 4352 | 5530 | 5928 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 77 | 110 | 149 | 124 | 119 | 111 | 173 | 209 | 151 |
| Cash Flow from Operating Activities | 361 | 261 | 102 | 181 | 153 | 337 | 395 | 325 | 536 |
| Cash Flow from Investing Activities | -263 | -185 | -45 | -102 | -57 | -60 | -93 | -146 | 124 |
| Cash Flow from Financing Activities | -65 | -37 | -81 | -84 | -104 | -215 | -267 | -238 | -554 |
| Net Cash Inflow / Outflow | 33 | 39 | -25 | -5 | -8 | 62 | 36 | -59 | 106 |
| Closing Cash & Cash Equivalent | 110 | 149 | 124 | 119 | 111 | 173 | 209 | 151 | 257 |
| # | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 31.57 | 28.17 | 28.15 | 21.41 | 38.97 | 42.09 | 34.44 | 60.17 | 57.16 |
| CEPS(Rs) | 33.19 | 32.44 | 29.03 | 24.33 | 41.81 | 45.01 | 37.77 | 66.34 | 67.08 |
| DPS(Rs) | 4 | 5 | 5 | 7 | 17 | 21 | 22 | 47 | 48 |
| Book NAV/Share(Rs) | 159.8 | 187.28 | 206.32 | 217.82 | 253.25 | 280.58 | 298.47 | 338.95 | 354.99 |
| Net Profit Margin | 38.19 | 33.87 | 33.42 | 31.78 | 42.3 | 40.53 | 34.71 | 46.17 | 43.92 |
| Operating Margin | 51.2 | 46.01 | 47.39 | 40.81 | 52.3 | 50.74 | 46.98 | 57.46 | 57.53 |
| PBT Margin | 50.3 | 46.01 | 47.15 | 39.45 | 51.6 | 50.05 | 46.23 | 56.81 | 56.84 |
| ROA(%) | 15.79 | 14.99 | 12.3 | 9.02 | 14.17 | 13.24 | 10.21 | 16.23 | 14.19 |
| ROE(%) | 19.51 | 18.04 | 14.1 | 10.22 | 16.55 | 15.79 | 11.96 | 19.79 | 18.36 |
| ROCE(%) | 26.15 | 24.5 | 20 | 13.1 | 20.29 | 19.48 | 15.9 | 24.18 | 23.7 |
| Price/Earnings(x) | 0 | 0 | 0 | 0 | 14.95 | 23.63 | 18.61 | 13.53 | 18.43 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 2.3 | 3.54 | 2.15 | 2.4 | 2.97 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 2.92 | 2.11 | 3.43 | 5.77 | 4.56 |
| EV/Net Sales(x) | 0.02 | -0.02 | 0 | 0.01 | 6.04 | 9.27 | 6.14 | 5.88 | 7.14 |
| EV/Core EBITDA(x) | 0.03 | -0.04 | 0.01 | 0.02 | 10.9 | 17.31 | 12.26 | 9.81 | 11.91 |
| Interest Earned Growth(%) | 0 | 13.23 | -10.12 | -17.87 | 35.1 | 12.87 | -3.96 | 37.11 | 6.57 |
| Net Profit Growth | 0 | 0.43 | -11.33 | -21.89 | 79.81 | 8.14 | -17.75 | 82.41 | 1.36 |
| EPS Growth(%) | 0 | -10.76 | -0.1 | -23.93 | 82.03 | 7.99 | -18.16 | 74.68 | -5 |
| Interest Coverage(x) % | 56.75 | 0 | 199.81 | 30.15 | 74.01 | 72.92 | 62.32 | 88.56 | 83.78 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| FII | 4.94 | 5.57 | 5.96 | 6.27 | 7.2 | 7.85 | 7.85 | 7.7 | 7.61 | 7.27 |
| DII | 61.69 | 61.13 | 60.92 | 60.66 | 60.19 | 59.27 | 59.71 | 59.47 | 59.71 | 60 |
| Public | 33.37 | 33.3 | 33.11 | 33.07 | 32.61 | 32.88 | 32.44 | 32.83 | 32.68 | 32.73 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| FII | 0.63 | 0.71 | 0.76 | 0.8 | 0.92 | 1 | 1.01 | 0.99 | 0.98 | 0.93 |
| DII | 7.83 | 7.78 | 7.75 | 7.72 | 7.67 | 7.58 | 7.64 | 7.62 | 7.66 | 7.71 |
| Public | 4.24 | 4.24 | 4.21 | 4.21 | 4.16 | 4.21 | 4.15 | 4.2 | 4.19 | 4.21 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12.7 | 12.72 | 12.73 | 12.73 | 12.75 | 12.79 | 12.8 | 12.81 | 12.82 | 12.85 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.